All Reports Events Blogs Videos
Showing 68 results
  • Thematic Report
    May 04, 2026

    The global Clinical Research Organization (CRO) market is undergoing a transformation, shaped by rising clinical trial complexity, increasing regulatory requirements, and growing demand for faster, more efficient drug development. CROs continue to play a pivotal role…
  • Viewpoint
    April 28, 2026

    The global safety database market is at an inflection point, driven by increasing complexities in Pharmacovigilance (PV) operations, growing regulatory expectations, and rapid expansion of data sources such as real-world evidence, digital health tools, and patient-generated…
  • Thematic Report
    March 31, 2026

    In today’s evolving talent landscape, organizations must consistently track key roles and skill sets across both established and emerging areas to make informed workforce-planning decisions. Elevated demand often reflects intensified competition for talent and potential attrition…
  • Viewpoint
    March 25, 2026

    Life sciences enterprises are operating in a market access environment defined by pricing reforms, heightened transparency, and evolving health technology assessment expectations. Market access now begins well before regulatory approvals, requiring early evidence alignment, global-local coordination,…
  • Voice of the Partner
    Dec. 15, 2025

    Global technology ecosystems are rapidly transforming as enterprises increasingly rely on channel partners to deliver integrated, outcome-driven solutions. As technology stacks expand and customer expectations rise, technology providers are reshaping their partner engagement models to drive…
  • Provider Compendium
    Nov. 06, 2025

    Clinical Data Management (CDM) operations have become a strategic priority for life sciences enterprises as they face growing trial complexities, expanding data volumes, and the integration of decentralized and real-world data sources. These dynamics are reshaping…
  • State of the Market
    Oct. 01, 2025

    The surge in case volumes, more stringent regulatory demands, and therapeutic areas’ rising complexities are significantly transforming pharmacovigilance (PV). As the industry adapts to more tailored reporting requirements and longer patient monitoring periods, enterprises are under…
  • Provider Compendium
    Sep. 30, 2025

    In recent years, life sciences enterprises have reoriented their R&D investments, prioritizing pipeline efficiency and a strategic focus on large and novel molecules. This shift has intensified efforts around cost containment and created a stronger need…
  • Tech Launch Perspective
    Sep. 25, 2025

    Zoho’s July 2025 product announcements signal a decisive move toward becoming an AI-first enterprise platform, with a particular focus on agentic AI. This report evaluates how Zoho’s ecosystem, including Zia Agents, Zia Agent Studio, and Zia…
  • Provider Compendium
    Sep. 16, 2025

    Pharmacovigilance (PV) operations have become a strategic priority for life sciences enterprises facing heightened regulatory scrutiny, evolving safety standards, and growing complexity across global markets. This report provides an in-depth assessment of 12 leading PV service…
  • Thematic Report
    Sep. 12, 2025

    In today’s dynamic talent landscape, organizations must continuously track both in-demand and emerging roles and skills to enable strategic workforce planning. Rising demand often signals heightened competition or increased attrition risk, making it critical to analyze…
  • Webinar Deck
    Aug. 29, 2025

    The life sciences industry has made significant strides in digitizing operations across clinical development and commercial engagement. However, many organizations still struggle with fragmented data, manual coordination, and delayed responses, hindering real-time decision-making. Systems of Execution…
  • PEAK Matrix®
    Aug. 19, 2025

    Clinical Data Management (CDM) is rapidly transforming as life sciences enterprises navigate increasing trial complexity, heightened regulatory scrutiny, and the expansion of decentralized and real-world data sources. CDM now plays a strategic role in enabling faster,…
  • Webinar Deck
    July 31, 2025

    Life sciences commercial teams are facing tighter budgets, faster launch cycles, and growing pressure to prove ROI from every investment and engagement. In this high-stakes environment, a new breed of specialist providers is stepping up, reshaping…
  • PEAK Matrix®
    July 16, 2025

    In recent years, life sciences enterprises have reprioritized and overhauled their R&D investments. They now focus on streamlining their pipelines and shifting toward new and large molecules. This transformation has compelled aggressive cost containment initiatives, prompting…
  • Viewpoint
    June 12, 2025

    Life sciences enterprises are increasingly turning to Real-world Evidence (RWE) as an essential input for decision-making across the product life cycle – from early-stage R&D to post-market access and safety. RWE offers validated insights into treatment…
  • Provider Recognition
    June 10, 2025

    What is the Everest Group BPS Top 50™? The Everest Group BPS Top 50™ is a global list of the 50 largest third-party providers, based on their Business Process Services (BPS) revenues and Year-on-Year (YoY) growth.…
  • Viewpoint
    June 03, 2025

    As life sciences enterprises navigate the clinical development’s growing complexity due to advanced therapies, increased data volumes, and the need for operational agility, outsourcing models are evolving in response. Sponsors now seek flexible, cost-efficient, and expertise-driven…
  • Viewpoint
    June 02, 2025

    The pharmaceutical industry is significantly transforming, driven by escalating R&D costs, rising competition, and a rapidly evolving global regulatory landscape. In this dynamic environment, regulatory affairs have emerged from their traditional compliance-focused roles to become strategic…
  • Viewpoint
    May 07, 2025

    Increasing trial complexity, growing data volumes, and the rise of decentralized and real-world data sources are fundamentally transforming the clinical trial landscape. Traditional Clinical Data Management (CDM) processes are largely manual and rely on siloed data…

Items per page